Literature DB >> 10092266

Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.

A J Hayes1, L Y Li, M E Lippman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10092266      PMCID： PMC1115280          DOI： 10.1136/bmj.318.7187.853

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  30 in total

Review 1.  Sequestration and release of basic fibroblast growth factor.

Authors:  I Vlodavsky; P Bashkin; R Ishai-Michaeli; T Chajek-Shaul; R Bar-Shavit; A Haimovitz-Friedman; M Klagsbrun; Z Fuks
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470.

Authors:  A P Kudelka; C F Verschraegen; E Loyer
Journal:  N Engl J Med       Date:  1998-04-02       Impact factor: 91.245

Review 3.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

4.  Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

Authors:  T Boehm; J Folkman; T Browder; M S O'Reilly
Journal:  Nature       Date:  1997-11-27       Impact factor: 49.962

5.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.

Authors:  K J Kim; B Li; J Winer; M Armanini; N Gillett; H S Phillips; N Ferrara
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

6.  Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.

Authors:  S W McLeskey; J Kurebayashi; S F Honig; J Zwiebel; M E Lippman; R B Dickson; F G Kern
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

7.  Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers.

Authors:  M Nguyen; H Watanabe; A E Budson; J P Richie; D F Hayes; J Folkman
Journal:  J Natl Cancer Inst       Date:  1994-03-02       Impact factor: 13.506

8.  Demonstration and characterization of the angiogenic properties of cervical dysplasia.

Authors:  K K Smith-McCune; N Weidner
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

9.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

10.  The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour.

Authors:  I F Tannock
Journal:  Br J Cancer       Date:  1968-06       Impact factor: 7.640
View more
  11 in total

1.  The role of funding and policies on innovation in cancer drug development.

Authors:  P Kanavos; R Sullivan; G Lewison; W Schurer; S Eckhouse; Z Vlachopioti
Journal:  Ecancermedicalscience       Date:  2010-02-03

Review 2.  The role of angiogenesis in prostate and other urologic cancers: a review.

Authors:  J I Izawa; C P Dinney
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

3.  Peroxisome proliferator-activated receptor γ and colorectal cancer.

Authors:  Yun Dai; Wei-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2010-03-15

Review 4.  Thalidomide in cancer treatment: a potential role in the elderly?

Authors:  Shufeng Zhou; Philip Kestell; Malcolm D Tingle; James W Paxton
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.

Authors:  Lin Jia; Mei-Hua Zhang; Shi-Zhen Yuan; Wen-Ge Huang
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

6.  Angiostatin up-regulation in gastric cancer cell SGC7901 inhibits tumorigenesis in nude mice.

Authors:  Jing Wu; Yong-Quan Shi; Kai-Chun Wu; De-Xin Zhang; Jing-Hua Yang; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

Review 7.  Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin.

Authors:  Li Zhang; Handong Wang
Journal:  Mar Drugs       Date:  2015-07-14       Impact factor: 5.118

8.  Microbubble and ultrasound radioenhancement of bladder cancer.

Authors:  W T Tran; S Iradji; E Sofroni; A Giles; D Eddy; G J Czarnota
Journal:  Br J Cancer       Date:  2012-07-12       Impact factor: 7.640

9.  A phase I study of the vascular endothelial growth factor inhibitor Vatalanib in combination with Pemetrexed disodium in patients with advanced solid tumors.

Authors:  Fen Wang; Julian Molina; Daniel Satele; Jun Yin; Vun-Sin Lim; Alex A Adjei
Journal:  Invest New Drugs       Date:  2018-10-31       Impact factor: 3.651

10.  Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model.

Authors:  S E Holwell; B T Hill; M C Bibby
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.